Related Experiment Video
Updated: Aug 15, 2025

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
Docetaxel treatment for widely metastatic invasive vulvar extramammary Paget's disease with multifocal bone
Larissa L Aroche Gutierrez1, Steven B Holloway2, Deepak Donthi3
1Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Gynecologic Oncology Reports
|December 29, 2022
Abstract:
•Invasive extramammary Paget's disease of the vulva is rare.•Distant metastasis has a very poor prognosis.•Given rarity of disease, no standardized treatment exists.•Single agent docetaxel is a viable treatment for metastatic invasive extramammary Paget's disease.

